Metro Brands Ltd

Metro Brands Ltd

₹ 1,032 -0.26%
04 Jun - close price
About

The company is one of the largest Indian footwear & accessories specialty retailers and are among the aspirational Indian brands in the footwear category.Its a one-stop shop for of branded products for the entire family, including men, women, unisex, and children, and for every occasion, including casual and formal events.[1]

Key Points

Network as of Q2 FY26[1][2]
Store Formats: 8
Stores: 966
States: 31
Cities: 211 (expanded 6 new cities H1 FY26)
Loyalty membership: 18+ mn
Vendors: 250

  • Market Cap 28,186 Cr.
  • Current Price 1,032
  • High / Low 1,340 / 883
  • Stock P/E 70.4
  • Book Value 71.6
  • Dividend Yield 0.53 %
  • ROCE 20.0 %
  • ROE 22.0 %
  • Face Value 5.00

Pros

  • Company has been maintaining a healthy dividend payout of 76.4%

Cons

  • Stock is trading at 14.4 times its book value
  • Working capital days have increased from 80.1 days to 142 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
527 556 532 624 578 563 567 688 632 615 636 789 757
385 361 371 426 412 383 418 464 437 422 469 530 523
Operating Profit 142 194 161 198 166 180 149 224 195 193 167 259 234
OPM % 27% 35% 30% 32% 29% 32% 26% 33% 31% 31% 26% 33% 31%
17 16 18 15 25 23 22 23 27 28 26 15 31
Interest 18 18 19 20 20 21 22 23 24 24 29 29 29
Depreciation 48 50 54 59 58 60 62 65 70 69 78 80 84
Profit before tax 93 142 106 133 113 123 88 158 128 129 86 166 153
Tax % 29% 25% 25% 28% -46% 25% 25% 40% 24% 25% 25% 25% 25%
66 106 79 96 165 92 66 94 97 97 64 125 115
EPS in Rs 2.44 3.91 2.92 3.52 6.05 3.40 2.41 3.46 3.58 3.55 2.35 4.60 4.20
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
702 767 868 1,034 1,155 1,210 789 1,312 2,071 2,305 2,450 2,797
577 632 722 818 925 867 608 906 1,403 1,598 1,700 1,943
Operating Profit 125 135 146 216 230 343 181 407 668 707 750 854
OPM % 18% 18% 17% 21% 20% 28% 23% 31% 32% 31% 31% 31%
7 3 9 8 17 23 76 55 51 65 94 100
Interest 0 0 0 0 0 39 44 50 63 78 90 111
Depreciation 12 13 16 19 22 120 121 134 178 228 257 310
Profit before tax 120 125 139 205 224 207 91 278 479 466 496 533
Tax % 34% 34% 34% 34% 34% 27% 20% 25% 26% 10% 30% 25%
79 82 92 135 148 152 73 208 354 418 350 400
EPS in Rs 53.84 55.71 62.13 91.78 11.14 11.44 2.73 7.65 13.03 15.37 12.84 14.69
Dividend Payout % 22% 22% 22% 22% 22% 26% 55% 29% 31% 33% 156% 41%
Compounded Sales Growth
10 Years: 14%
5 Years: 29%
3 Years: 11%
TTM: 14%
Compounded Profit Growth
10 Years: 17%
5 Years: 41%
3 Years: 5%
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 3%
1 Year: -16%
Return on Equity
10 Years: 22%
5 Years: 22%
3 Years: 22%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 15 15 15 15 133 133 133 136 136 136 136 136
Reserves 314 374 441 547 532 647 672 1,102 1,378 1,699 1,543 1,817
0 0 0 0 0 536 566 692 938 1,098 1,227 1,570
103 99 150 164 219 190 242 324 376 356 364 413
Total Liabilities 431 488 606 726 884 1,506 1,612 2,255 2,828 3,289 3,271 3,936
122 134 170 183 222 705 722 847 1,286 1,476 1,597 1,984
CWIP 0 1 4 6 4 13 5 6 18 9 9 14
Investments 37 77 96 184 208 346 397 398 496 765 552 675
272 277 336 352 450 443 488 1,004 1,028 1,039 1,112 1,263
Total Assets 431 488 606 726 884 1,506 1,612 2,255 2,828 3,289 3,271 3,936

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
83 157 107 272 244 218 372 585 687 476
-84 -93 -67 -161 -116 -299 -47 -250 129 -100
0 -53 -44 -112 -116 118 -355 -319 -768 -436
Net Cash Flow -1 10 -4 -1 12 38 -30 16 48 -60
Free Cash Flow 25 124 49 229 219 171 280 470 600 337
CFO/OP 88% 102% 79% 96% 146% 71% 77% 94% 109% 71%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 1 1 2 2 3 2 10 6 8 6 7 6
Inventory Days 215 219 219 207 234 221 295 278 265 266 223 263
Days Payable 85 77 86 104 127 107 210 140 120 96 79 86
Cash Conversion Cycle 131 144 134 105 110 117 95 144 153 176 151 184
Working Capital Days 73 70 57 47 56 33 13 33 47 47 52 142
ROCE % 40% 35% 32% 40% 37% 25% 10% 20% 24% 20% 20% 20%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Average Realization per Pair
INR

Log in to view insights

Please log in to see hidden values.

Login
E-commerce Revenue Contribution
Percentage
Loyalty Membership
Millions
Number of Cities Present
Number
Revenue Contribution of In-house Brands (MBO)
Percentage
Revenue per Square Foot
INR
Total Store Count
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.20% 74.20% 74.17% 74.16% 74.16% 71.95% 71.93% 71.88% 71.87% 71.86% 71.83% 71.80%
2.61% 2.33% 2.69% 2.68% 3.05% 3.39% 3.43% 3.46% 3.65% 3.88% 3.81% 3.77%
5.72% 6.10% 5.98% 6.02% 5.59% 7.00% 7.18% 7.36% 7.39% 7.36% 7.51% 7.58%
17.45% 17.36% 17.16% 17.13% 17.19% 17.64% 17.47% 17.30% 17.09% 16.90% 16.84% 16.86%
No. of Shareholders 63,45162,69058,87262,65364,47071,25868,34267,17664,90761,32460,18959,425

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls